CERS
Price
$1.72
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
NEO
Price
$13.48
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
6 days until earnings call
Ad is loading...

CERS vs NEO

Header iconCERS vs NEO Comparison
Open Charts CERS vs NEOBanner chart's image
Cerus
Price$1.72
Change-$0.00 (-0.00%)
Volume$3.17M
CapitalizationN/A
NeoGenomics
Price$13.48
Change-$0.00 (-0.00%)
Volume$358.71K
CapitalizationN/A
View a ticker or compare two or three
CERS vs NEO Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CERS vs. NEO commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Buy and NEO is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (CERS: $1.72 vs. NEO: $13.48)
Brand notoriety: CERS and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 251% vs. NEO: 49%
Market capitalization -- CERS: $342.62M vs. NEO: $2.01B
CERS [@Medical Specialties] is valued at $342.62M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, CERS is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 4 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • CERS’s TA Score: 4 bullish, 5 bearish.
  • NEO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NEO is a better buy in the short-term than CERS.

Price Growth

CERS (@Medical Specialties) experienced а +2.38% price change this week, while NEO (@Medical Specialties) price change was +2.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

CERS is expected to report earnings on Feb 20, 2025.

NEO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than CERS($343M). NEO YTD gains are higher at: -16.687 vs. CERS (-20.370). NEO has higher annual earnings (EBITDA): -17.61M vs. CERS (-26.34M). NEO has more cash in the bank: 415M vs. CERS (65.9M). CERS has less debt than NEO: CERS (96M) vs NEO (612M). NEO has higher revenues than CERS: NEO (592M) vs CERS (156M).
CERSNEOCERS / NEO
Capitalization343M2.01B17%
EBITDA-26.34M-17.61M150%
Gain YTD-20.370-16.687122%
P/E RatioN/A49.50-
Revenue156M592M26%
Total Cash65.9M415M16%
Total Debt96M612M16%
FUNDAMENTALS RATINGS
CERS vs NEO: Fundamental Ratings
CERS
NEO
OUTLOOK RATING
1..100
104
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
6279
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (51) in the Medical Specialties industry is in the same range as NEO (67) in the Medical Or Nursing Services industry. This means that CERS’s stock grew similarly to NEO’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CERS’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (93) in the Medical Or Nursing Services industry is in the same range as CERS (96) in the Medical Specialties industry. This means that NEO’s stock grew similarly to CERS’s over the last 12 months.

CERS's Price Growth Rating (62) in the Medical Specialties industry is in the same range as NEO (79) in the Medical Or Nursing Services industry. This means that CERS’s stock grew similarly to NEO’s over the last 12 months.

CERS's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CERS’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSNEO
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+2.99%
MASS - CERS
52%
Loosely correlated
+3.04%
FLGT - CERS
48%
Loosely correlated
+2.57%
KIDS - CERS
44%
Loosely correlated
+1.71%
BLFS - CERS
44%
Loosely correlated
+3.77%
BNGO - CERS
44%
Loosely correlated
+1.37%
More